Augmented Definitive Screening Design Provides Efficient Phase 1 Selection of CAR T-cell and Lymphodepletion Regimen Poster Augmented Definitive Screening Design Provides Efficient Phase 1 Selection of CAR T-cell and Lymphodepletion Regimen CertaraNovember 22, 2024
Oncology MIDD Simulator, A User-Friendly Application for Overall Survival Forecasting in Early Oncology Trials Poster Oncology MIDD Simulator, A User-Friendly Application for Overall Survival Forecasting in Early Oncology Trials CertaraNovember 22, 2024
Quantitative Systems Pharmacology model for combined targeting of BAFF and CD40 pathways in systemic lupus erythematosus Poster Quantitative Systems Pharmacology model for combined targeting of BAFF and CD40 pathways in systemic lupus erythematosus CertaraNovember 22, 2024
Population pharmacokinetic modeling of niraparib to assess different absorption models Poster Population pharmacokinetic modeling of niraparib to assess different absorption models CertaraNovember 22, 2024
Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women Publication Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women The article "Recent Applications of Pharmacometrics and Systems Pharmacology Approaches to Improve and Optimize Drug…CertaraNovember 18, 2024
Enhancing Pharmacokinetics Workflows at Charles River Case Study Enhancing Pharmacokinetics Workflows at Charles River PreclinicalPhoenix™ Integral Data Repository Charles River, a global leader in drug development, sought to improve…CertaraNovember 13, 2024
A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric Population Publication A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric Population CertaraNovember 7, 2024
Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody Publication Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody The article titled "Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a…CertaraNovember 4, 2024
Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women Publication Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women The article titled "Using PBPK modeling to supplement clinical data and support the safe and…CertaraOctober 30, 2024
On-ramps to popPK: Building Better Models with GUI, Code, or Both On-Demand Webinar On-ramps to popPK: Building Better Models with GUI, Code, or Both A critical component of popPK studies is popPK modeling, where mathematical models are developed to…CertaraOctober 18, 2024